Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navelbine and Taxotere as First-Line Therapy for Metastatic Breast Cancer
NCT00006682Phase 2Completed
- Sponsor
- MedStar Health Research Institute
- Start
- Feb 2000
- Primary completion
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, docetaxel in breast cancer, sponsored by MedStar Health Research Institute. Started Feb 2000; status: completed.
02
Drugs
vinorelbinedocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00006682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006682.